Immix Biopharma (IMMX) Shareholder's Equity (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 84.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.36 Mn |
| Dec 31, 2025 | 93.80 Mn |
| Sep 30, 2025 | 8.26 Mn |
| Jun 30, 2025 | 4.65 Mn |
| Mar 31, 2025 | 9.59 Mn |
| Dec 31, 2024 | 13.25 Mn |
| Sep 30, 2024 | 17.55 Mn |
| Jun 30, 2024 | 23.89 Mn |
| Mar 31, 2024 | 27.63 Mn |
| Dec 31, 2023 | 16.20 Mn |
| Sep 30, 2023 | 19.65 Mn |
| Jun 30, 2023 | 13.17 Mn |
| Mar 31, 2023 | 11.74 Mn |
| Dec 31, 2022 | 13.16 Mn |
| Sep 30, 2022 | 16.75 Mn |
| Jun 30, 2022 | 18.11 Mn |
| Mar 31, 2022 | 19.65 Mn |
| Dec 31, 2021 | 17.99 Mn |
| Sep 30, 2021 | -6.20 Mn |
| Jun 30, 2021 | -5.85 Mn |
| Mar 31, 2021 | -5.71 Mn |
| Dec 31, 2020 | -4.73 Mn |